Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abeona, Actinium, Aelix, Albireo, Apeiron, Aramis, Arbutus, Ardelyx, Atea, Biontech, Biophytis, Blaze, Chinook, Clairvoyant, Compass, Daewoong, Emergent, G1, GSK, Inozyme, Lianbio, Madrigal, Neurocrine, Neurotech, Ose, Pfizer, Regenxbio, Regulus, Renovion, Rhythm, Rigel, Sagimet, Sonnet, Surface Oncology, Syndax, Theriva, Transgene, Uniqure, Vectivbio.